Vir Biotechnology (NasdaqGS:VIR) Q1 2026 Earnings call May 06, 2026 04:30 PM ET Company ParticipantsJason O'Byrne - CFOKiki Patel - Head of Investor RelationsMarianne De Backer - CEOConference Call ParticipantsJoseph Stringer - AnalystJosh Chazaro - AnalystLuis Santos - AnalystMatthew Guggenbiller - AnalystMichael Ahn - AnalystPaul Choi - AnalystPhil Nadeau - AnalystSean McCutcheon - AnalystNone - AnalystOperatorHello, and welcome to Vir Biotechnology's first quarter 2026 financial results and corporate upd ...